SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-20-000012
Filing Date
2020-02-27
Accepted
2020-02-27 07:19:48
Documents
3
Period of Report
2020-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q419earningsrelease-8xk.htm 8-K 32739
2 EXHIBIT 99.1 q419earningsrelease.htm EX-99.1 97831
3 cnceimagea01.jpg GRAPHIC 7277
  Complete submission text file 0001367920-20-000012.txt   141925
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 20658465
SIC: 2834 Pharmaceutical Preparations